The pandemic continued to remake the pharma and biotech industry this past year. A handful of companies fared exceptionally well at commercializing COVID-19 therapies. This fact promises to lead to sizable shifts in the rankings of pharma leaders. These trends were not yet evident in our spring roundup of the 50 largest pharma companies, which…
Lupin wins FDA approval for Solosec as treatment of trichomoniasis
Mumbai, India–headquartered Lupin Pharmaceuticals (NYSE:LUPIN) has received an expanded indication for Solosec (secnidazole) to cover the treatment of trichomoniasis in adult patients and their partners. The drug scored an initial FDA approval in 2017 for bacterial vaginosis (BV) in adult women. Solosec is now the only single-dose oral drug that has an FDA indication for both…